CC-486
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for CC-486, covering 2014-02-04 to 2026-04-28. Get the full timeline:
Most recent: Clinical Trial Update: Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma [Phase 2, Phase 3]